SHWGY (Shandong Weigao Group Medical Polymer Co) LT-Debt-to-Total-Asset: 0.13 (As of Dec. 2025)

What is Shandong Weigao Group Medical Polymer Co LT-Debt-to-Total-Asset?

Shandong Weigao Group Medical Polymer Co SHWGY +6.90% 70 LT-Debt-to-Total-Asset is 0.13 as of Dec. 2025. GuruFocus rates SHWGY with a GF Score™ of 70/100 and a GF Value™ of $3.04 (Significantly Undervalued). The stock has 7 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shandong Weigao Group Medical Polymer Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.13.

Shandong Weigao Group Medical Polymer Co's long-term debt to total assets ratio increased from Dec. 2024 (0.09) to Dec. 2025 (0.13). It may suggest that Shandong Weigao Group Medical Polymer Co is progressively becoming more dependent on debt to grow their business.

Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shandong Weigao Group Medical Polymer Co LT-Debt-to-Total-Asset Related Terms

Shandong Weigao Group Medical Polymer Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Group Medical Polymer Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Group Medical Polymer Co LT-Debt-to-Total-Asset Chart

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.12

0.11

0.05

0.09

0.13

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.05	0.10	0.09	0.13	0.13

70GF Score

Shandong Weigao Group Medical Polymer Co Ltd SHWGY

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Shandong Weigao Group Medical Polymer Co LT-Debt-to-Total-Asset Calculation

Shandong Weigao Group Medical Polymer Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	653.824	/	5118.143
	=	0.13

Shandong Weigao Group Medical Polymer Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	653.824	/	5118.143
	=	0.13

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.13 mean?

Shandong Weigao Group Medical Polymer Co (SHWGY) has a LT-Debt-to-Total-Asset of 0.13 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors.

Is Shandong Weigao Group Medical Polymer Co's LT-Debt-to-Total-Asset too high?

Shandong Weigao Group Medical Polymer Co's current LT-Debt-to-Total-Asset is 0.13. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Shandong Weigao Group Medical Polymer Co's LT-Debt-to-Total-Asset compare to ISRG and BDX?

Shandong Weigao Group Medical Polymer Co's LT-Debt-to-Total-Asset of 0.13 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?

A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. Shandong Weigao Group Medical Polymer Co's current LT-Debt-to-Total-Asset is 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?

Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.04, compared to a current price of $1.60 — trading 47.5% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.13. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current LT-Debt-to-Total-Asset is 0.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued. The current stock price of $1.60 is trading 47.5% below its estimated GF Value™ of $3.04. GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.

Key valuation signals for SHWGY:

LT-Debt-to-Total-Asset: 0.13
GF Value™: $3.04 vs. price of $1.60 (47.5% below fair value)
GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Weigao Group Medical Polymer Co Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies HKSE:02276 HKSE:06699 HKSE:01501 HKSE:03600 HKSE:06929 HKSE:01358 HKSE:01120 HKSE:00876 HKSE:00630 HKSE:01134 ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543

Other Exchanges SHWGF:USA 01066:Hong Kong UK2:Germany

Address No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

70GF Score

Get the complete analysis for SHWGY

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.60

Price

$3.04

GF Value

View SHWGY Analysis

See LT-Debt-to-Total-Asset data for all stocks →